Monitor future Form 4 filings by John Drayton Wise for any open-market purchases or sales, which would provide a clearer signal of insider conviction. This Form 3 alone is a procedural filing with no trading implications.
Price Chart
Executive Summary
John Drayton Wise filed a Form 3 initial statement of beneficial ownership with IRulya Therapeutics Inc., indicating he has become a reporting person (officer, director, or >10% holder). The filing is a routine Section 16 compliance requirement and contains no financial data or transaction details.
Key Facts
- John Drayton Wise filed a Form 3 initial statement of beneficial ownership with IRulya Therapeutics Inc. on 2026-10-19, covering the period ending 2026-10-08.
- The filing includes a Power of Attorney (Ex-24) authorizing Brigette Roberts and John Militello to execute future Forms 3, 4, and 5 on his behalf.
- No securities ownership amounts, transaction details, or financial figures are disclosed in the filing.
Financial Impact
No financial impact — the filing is a routine initial ownership disclosure with no transaction or financial data.
Risk Factors
- No material risks identified from this routine filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001930805-26-000004 |
| Document: 0001930805-26-000004-index-headers.html | 0001930805-26-000004 |
| Document: 0001930805-26-000004-index.html | 0001930805-26-000004 |
| Document: 0001930805-26-000004.txt | 0001930805-26-000004 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | 144 | $32.83 | awaiting T+20 | — | $32.47 (−1.08%) |
Oct 19, 2026 8d ago | 3 | $40.27 | awaiting T+20 | — | $32.47 (−19.36%) |
Oct 19, 2026 8d ago | 3 | $40.27 | awaiting T+20 | — | $32.47 (−19.36%) |
Oct 19, 2026 8d ago | 3 | $40.27 | awaiting T+20 | — | $32.47 (−19.36%) |
Oct 19, 2026 8d ago | 3 | $40.27 | awaiting T+20 | — | $32.47 (−19.36%) |
Oct 19, 2026 8d ago | 3 | $40.27 | awaiting T+20 | — | $32.47 (−19.36%) |
Oct 19, 2026 8d ago | 8-K | $34.45 | awaiting T+20 | — | $32.47 (−5.73%) |
Oct 14, 2026 13d ago | SC 13G | $33.23 | awaiting T+20 | — | $32.47 (−2.27%) |
Oct 14, 2026 13d ago | SC 13G | $33.23 | awaiting T+20 | — | $32.47 (−2.27%) |
Oct 6, 2026 21d ago | 8-K | $26.72 | awaiting T+20 | — | $32.47 (+21.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers